(0.19%) 5 141.25 points
(0.13%) 38 490 points
(0.31%) 17 901 points
(-0.45%) $83.47
(1.61%) $1.954
(0.13%) $2 350.20
(0.37%) $27.64
(1.19%) $933.05
(-0.01%) $0.935
(-0.12%) $11.01
(-0.12%) $0.799
(1.27%) $93.04
3 days till quarter result
(bmo 2024-05-02)
Expected move: +/- 10.78%
@ $107.64
发出时间: 27 Apr 2024 @ 02:21
回报率: 0.31%
上一信号: Apr 26 - 01:42
上一信号:
回报率: 1.97 %
Live Chart Being Loaded With Signals
Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases in the United States, Europe, and internationally...
Stats | |
---|---|
今日成交量 | 2.24M |
平均成交量 | 3.76M |
市值 | 41.34B |
EPS | $0 ( 2024-02-22 ) |
下一个收益日期 | ( $-3.59 ) 2024-05-02 |
Last Dividend | $0 ( N/A ) |
Next Dividend | $0 ( N/A ) |
P/E | -8.76 |
ATR14 | $2.76 (2.55%) |
Date | Person | Action | Amount | type |
---|---|---|---|---|
2024-04-24 | Afeyan Noubar | Sell | 3 926 | Common Stock |
2024-04-24 | Afeyan Noubar | Sell | 5 821 | Common Stock |
2024-04-24 | Afeyan Noubar | Sell | 4 153 | Common Stock |
2024-04-24 | Afeyan Noubar | Sell | 1 100 | Common Stock |
2024-04-17 | Afeyan Noubar | Sell | 8 243 | Common Stock |
INSIDER POWER |
---|
31.12 |
Last 100 transactions |
Buy: 525 652 | Sell: 274 802 |
音量 相关性
Moderna Inc 相关性
10 最正相关 |
---|
10 最负相关 |
---|
你知道吗?
相关性是描述两个变量之间关系的统计指标。它的取值范围为-1到1,其中-1表示完全负相关(一个变量增加,另一个变量减少),1表示完全正相关(一个变量增加,另一个变量也增加),0表示没有相关性(变量之间没有关系)。
相关性可用于分析任何两个变量之间的关系,而不仅仅是股票。它通常用于金融、经济学、心理学等领域。
Moderna Inc 相关性 - 货币/商品
Moderna Inc 财务报表
Annual | 2023 |
营收: | $6.75B |
毛利润: | $2.06B (30.52 %) |
EPS: | $-12.34 |
FY | 2023 |
营收: | $6.75B |
毛利润: | $2.06B (30.52 %) |
EPS: | $-12.34 |
FY | 2022 |
营收: | $19.26B |
毛利润: | $13.85B (71.88 %) |
EPS: | $21.22 |
FY | 2021 |
营收: | $18.47B |
毛利润: | $15.85B (85.83 %) |
EPS: | $30.31 |
Financial Reports:
No articles found.
Moderna Inc
Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, flu, respiratory syncytial virus, Endemic HCoV, and hMPV+PIV3 vaccines; latent vaccines comprise cytomegalovirus, epstein-barr virus, human immunodeficiency virus, herpes simplex virus, and varicella-zoster virus vaccines; and public health vaccines consists of Zika and Nipah vaccines. The company also offers systemic secreted and cell surface therapeutics; cancer vaccines, such as personalized cancer, KRAS, and checkpoint vaccines; intratumoral immuno-oncology products; localized regenerative, systemic intracellular, and inhaled pulmonary therapeutics. It has strategic alliances with AstraZeneca PLC; Merck & Co., Inc.; Vertex Pharmaceuticals Incorporated; Vertex Pharmaceuticals (Europe) Limited; Carisma Therapeutics, Inc.; Metagenomi, Inc.; the Defense Advanced Research Projects Agency; Biomedical Advanced Research and Development Authority; Institute for Life Changing Medicines; and The Bill & Melinda Gates Foundation, as well as a collaboration and license agreement with Chiesi Farmaceutici S.P.A. The company was formerly known as Moderna Therapeutics, Inc. and changed its name to Moderna, Inc. in August 2018. Moderna, Inc. was founded in 2010 and is headquartered in Cambridge, Massachusetts.
关于 实时信号
此页面上呈现的实时信号有助于确定何时购买或出售NA. 信号具有高达1分钟的延迟;与所有市场信号一样,存在误差或错误的可能性。
实时交易信号不是绝对的,getagraph.com 对基于这些信号采取的任何行动概不负责,如《使用条款》中所述。这些信号是基于广泛的技术分析指标。